DIRS.INFO The most relevant business & tech news

☆ China is gunning for the chief scientist of its COVID vaccine project, accusing him of 'serious discipline and law violations'
▼ + stars: | 2024-04-29 | by ( Matthew Loh | ) www.businessinsider.com time to read: +1 min

The chief scientist of China's COVID vaccine project was kicked from the National People's Congress. Yang Xiaoming, 62, is accused of "serious discipline and law violations," a phrase alluding to corruption. Yang led the team that developed the Sinopharm vaccine, and was China's top researcher in its vaccine project. AdvertisementThe chief researcher of China's first general-use COVID vaccine was ousted last week from the country's highest organ of power. Yang Xiaoming, 62, was booted on April 23 from the National People's Congress "due to serious discipline and law violations," state media reported this weekend.

Persons: Yang Xiaoming, Yang, —, China's Organizations: National People's, Service, Business Locations: China

☆ Chinese property developer Country Garden to be removed from Hang Seng Index on Sept. 4
▼ + stars: | 2023-08-21 | by ( Lim Hui Jie | ) www.cnbc.com time to read: 1 min

The headquarters of China's developer Country Garden Holdings in Foshan, in China's southern Guangdong province. Chinese real estate company Country Garden Holdings is set to be removed from Hong Kong's Hang Seng Index on Sept. 4. The index's operator said Country Garden will be replaced by pharmaceutical firm Sinopharm. Property management firm and affiliate Country Garden Services Holdings will also be removed from the Hang Seng China Enterprises Index. The Hang Seng China Enterprises Index serves as a benchmark that reflects the overall performance of mainland securities listed in Hong Kong.

Organizations: Garden Holdings, Garden Services Holdings, Hang Seng China Enterprises, Seng China Enterprises Locations: Foshan, China's, Guangdong, Hong Kong

☆ CNBC Daily Open: Unwelcome déjà vu in U.S. markets
▼ + stars: | 2023-08-21 | by ( Yeo Boon Ping | ) www.cnbc.com time to read: +2 min

This report is from today's CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Japan's Nikkei 225 added 0.75%, but Hong Kong's Hang Seng Index dropped 1.38%. Beleaguered Chinese real estate company Country Garden will be removed from Hong Kong's index on Sept. 4 and replaced by Sinopharm. It wasn't just U.S. markets that fell — Hong Kong's Hang Seng Index closed in bear market territory Friday.

Persons: Jay Hatfield, Jackson, Sarah Min, Jerome Powell's Organizations: CNBC, Nikkei, Global, Elon, SpaceX, Capital Management Locations: Asia, Pacific, U.S

☆ CDC eases certain Covid-19 vaccine requirements for international travelers to US
▼ + stars: | 2023-04-28 | by ( Brenda Goodman | ) edition.cnn.com time to read: +2 min

CNN —The US Centers for Disease Control and Prevention is still requiring international visitors boarding flights to the United States to be vaccinated against Covid-19, but it’s easing vaccine requirements for those travelers. International travelers boarding flights to the United States will now be considered fully vaccinated two weeks after getting a single dose of either the Pfizer or Moderna mRNA vaccine any time after August 16, 2022, when bivalent formulations first became available. Previously, foreign travelers entering the United States were considered fully vaccinated two weeks after the second dose of a vaccine that required two primary doses, or two weeks after a vaccine that only required a single shot, such as the Johnson & Johnson vaccine. A number of older, monovalent vaccine regimens also qualify a foreign visitor as fully vaccinated. As part of the update, the older monovalent mRNA Covid-19 vaccines are no longer recommended in the United States, and updated vaccines are recommended for everyone age 6 months and older.

☆ Pfizer signs strategic cooperation pact with China's Sinopharm
▼ + stars: | 2023-04-13 | by ( ) www.reuters.com time to read: 1 min

April 13 (Reuters) - Pfizer (PFE.N) said on Thursday it has signed a strategic cooperation agreement with China's Sinopharm Group (1099.HK), and plans to seek approval to market 12 innovative drugs in China through 2025. Sinopharm's president Liu Yong said during the signing event in Shanghai on Wednesday that the cooperation will involve accelerating the delivery of Pfizer's new drugs to patients, according to a statement from Pfizer. Reporting by Brenda Goh, Meg Shen and Ethan Wang; Editing by Bernadette BaumOur Standards: The Thomson Reuters Trust Principles.

☆ China approves its first mRNA Covid-19 vaccine
▼ + stars: | 2023-03-23 | by ( Juliana Liu | ) edition.cnn.com time to read: +1 min

Hong Kong CNN —China has approved its first Covid-19 vaccine based on mRNA technology, months after the country lifted strict pandemic measures. The vaccine targets the Omicron variant and was tested in China with over 5,500 people, it added. “This is a positive step because there is strong scientific evidence that mRNA vaccines do much better than non-MRA vaccines,” Jin Dong-yan, a professor in molecular virology at the University of Hong Kong, told CNN. Until now, China has approved only inactivated vaccines made by Sinovac Biotech and Sinopharm Group, two Beijing-based drugmakers. The inactivated vaccines have been found to elicit lower levels of antibody response compared to ones using the newer messenger RNA technology.

☆ China should set aside politics and look at Covid jab imports, world's largest vaccine maker says
▼ + stars: | 2023-01-16 | by ( Jenni Reid | ) www.cnbc.com time to read: +1 min

China needs to move past political considerations and look at importing Covid-19 jabs to end the pandemic globally, according to the chief executive of the world's latest vaccine manufacturer. The main Covid vaccines approved for use in China are from Sinovac and Sinopharm. These jabs are less effective against the Omicron variant than are other mRNA vaccines, such as Pfizer and BioNTech's, several studies have found. Poonawalla said China's pandemic reaction of 2020 — which included building hospitals and infrastructure and taking precautions — showed that Beijing could respond rapidly. He stressed China's decision not to import vaccines from the U.S., India and elsewhere, which have been "very effective."

☆ Mainland Chinese citizens are eager to travel — for the West's mRNA Covid vaccines
▼ + stars: | 2023-01-10 | by ( Lee Ying Shan | ) www.cnbc.com time to read: +4 min

Passengers prepare to enter Shenzhen through the Lok Ma Chau Spur Line Control Point on the first day of the resumption of normal travel between Hong Kong and mainland China on Jan. 8, 2023 in Hong Kong. Analysts expect that the list of destinations for vaccine tourism will grow. 'Natural first destination': Hong Kong"I believe that the natural first destination of the Chinese vaccine tourism is Hong Kong. "It's been long since I went to Hong Kong. But Hong Kong won't provide free Covid vaccinations to short-term travelers.

☆ 'I don't trust it:' Vaccine hesitancy lingers even as China COVID cases surge
▼ + stars: | 2022-12-19 | by ( David Kirton | ) www.reuters.com time to read: +4 min

"I don't trust it," she said, speaking on the condition that only her first name be used. It has also yet to introduce its own version of an mRNA vaccine. "At least a half of doctors and educated people wanted to get the mRNA ones and refused to get the Chinese ones," Lei said. "After a while, people see no hope and also they are kind of forced to get the Chinese ones, so they had to accept it. Lei said many of her friends are looking to visit the neighbouring Chinese territory of Macau, where mainlanders can receive mRNA vaccines.

SYDNEY/BEIJING, Dec 15 (Reuters) - The rising alarm over COVID-19 spreading in China was felt in pharmacies in Hong Kong, Macau, and in some neighbourhoods in Australia, as people hunted for fever medicines and virus test kits to send to family and friends on the mainland. Several shops have since imposed limits on how much customers can buy, and drugmakers are ramping up production. They like to hoard medicines before they even get sick," said a doctor in Shanghai. "I have friends in Beijing who asked me to send over some flu medicines and rapid tests. And the government-backed Sinopharm Group has tripled daily production capacity of key drugs, state run CCTV reported, due to a sharp increase in demand for medicines to treat fever and cough symptoms.

The Chinese pharmaceutical giant may revive a buyout of its 32%-owned traditional medicine arm listed in Hong Kong. The state-backed group's latest bid for China Traditional Chinese Medicine (0570.HK) looks generous. China TCM's woes are a stark contrast to mainland-listed rivals, including some with heavy exposure to drugs presented as fixes to Covid-19. Assuming some of that enthusiasm can rub off on China TCM, that makes Sinopharm's latest offer look like a steal. Follow @mak_robyn on TwitterloadingCONTEXT NEWSSinopharm is considering reviving a bid for China Traditional Chinese Medicine Holdings, Bloomberg reported on Dec. 7, citing people familiar with the matter.

☆ China's people are protesting the country's severe zero-COVID policies, and public-health experts agree with them
▼ + stars: | 2022-11-29 | by ( Morgan Mcfall-Johnsen | Paola Rosa-Aquino | ) www.businessinsider.com time to read: +7 min

Protests are erupting across China over the country's restrictive zero-COVID policies. Public-health experts say the policies are unsustainable, ineffective, and unnecessarily severe. Without vaccination campaigns targeting older adults, China's lockdowns may only delay a catastrophic COVID wave. Tyrone Siu/ReutersThere is no easy way forward for China, but constant 2020-style lockdowns are not the solution, according to public-health experts, who called the policies unsustainable, ineffective, and irrational. As a result, Huang thinks the zero-COVID lockdowns are completely unwarranted.

☆ Merck agrees to allow Sinopharm to sell molnupiravir COVID drug in China
▼ + stars: | 2022-09-28 | by ( ) www.reuters.com time to read: +1 min

NEW YORK, Sept 28 (Reuters) - Drugmaker Merck & Co (MRK.N) said on Wednesday that it agreed to allow China's Sinopharm (1099.HK) to distribute and import its COVID-19 antiviral molnupiravir in China if the drug is approved for use there. The drugmaker said in a statement that it reached a cooperation framework agreement with Sinopharm that grants the Chinese company distribution and exclusive import rights of the medicine in the China mainland market. Merck also said it will allow China National Biotec Group, an affiliate of Sinopharm, to make the drug in China and has agreed to transfer technology to help with that production. Molnupiravir is sold under the brand name Lagevrio in the U.S. Merck developed the pill - and shares the profits equally - with partner Ridgeback Biotherapeutics. Register now for FREE unlimited access to Reuters.com RegisterReporting by Michael Erman; editing by Jonathan OatisOur Standards: The Thomson Reuters Trust Principles.

☆ Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms
▼ + stars: | 2022-09-28 | by ( Spencer Kimball | ) www.cnbc.com time to read: +2 min

However, the longer menstrual cycle, typically about a month long, didn't necessarily increase the number of days of bleeding, according to NIH. A change in menstrual cycle length of eight days or less is considered within the normal range of variation, according to NIH. Women who received both vaccine doses in a single menstrual period saw their cycle increase by 3.91 days. The changes in menstrual cycle length did not differ between vaccines. The researchers had released preliminary findings in January suggesting an association between Covid vaccination and increased menstrual cycle length, but the study published this week confirmed the link.

☆ I help foreigners get settled in Dubai. There's been a surge in interest from Russians to move to the city — here's what they're looking for.
▼ + stars: | 2022-03-21 | by ( Mark Ellwood | ) www.businessinsider.com time to read: +9 min

We offer all the services that come with starting up in Dubai: visas, taxes, accounting, relocation, real estate. Dubai has been working on its image for many years, and now it's up there with London or Monaco, in my opinion. Russian clients usually speak English, but they'll prefer to deal with Russian speakers. There's a feeling about Dubai that shady people can come here, set up, and get away with itIt's a real process here. In general, Russians prefer villas to apartmentsSince COVID-19, there's been a boom in villas — everyone wants them.

☆ STUDIU: Anticorpii împotriva COVID-19 durează până la 12 luni la 70 % dintre pacienţii recuperaţi
▼ + stars: | 2021-07-08 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +2 min

Anticorpii împotriva coronavirusului SARS-CoV-2 pot dura până la 12 luni la peste 70% dintre pacienţii care s-au recuperat de COVID-19, potrivit unui studiu publicat de cercetători chinezi şi preluat joi de mass-media locale, relatează EFE.Studiul relevă că vaccinarea poate "restrânge efectiv răspândirea" coronavirusului, având în vedere că oferă un răspuns imunitar similar modului în care organismul uman generează anticorpi împotriva virusurilor vii, scrie agerpres.ro Studiul a fost realizat de o filială a companiei farmaceutice Sinopharm - care produce două dintre vaccinurile aprobate de guvernul chinez - şi de Centrul de Cercetare Translaţională şi Medicină al Universităţii Jiaotong, din Shanghai.Pentru acest studiu au fost prelevate 1.800 mostre de plasmă convalescentă de la 869 de persoane care s-au recuperat de COVID-19 după 12 luni de la infectarea lor la Wuhan, oraşul unde s-a detectat primul focar mondial de coronavirus în decembrie 2019.Cercetătorii au verificat prezenţa şi cantitatea în aceste mostre de RBDIgG, un tip de anticorp ce indică nivelul de imunitate împotriva virusului.Potrivit rezultatelor, la 9 luni de la boală anticorpii s-au redus cu 64,3 % faţă de nivelul când pacienţii au contractat virusul dar au rămas stabili până în luna a 12-a.Răspunsul imunitar a fost mai puternic la bărbaţi decât la femei în primele etape ale infecţiei, însă diferenţa s-a estompat şi a dispărut cu totul după 12 luni.De asemenea, persoanele din categoria de vârstă 18 - 55 de ani au dezvoltat nivele mai ridicate de anticorpi.Potrivit Grupului Naţional de Biotehnologie din China - filiala Sinopharm care l-a desfăşurat - este vorba de cel mai extins studiu dintre cele realizate până acum pentru a verifica continuitatea răspunsului imunitar la pacienţii recuperaţi de COVID-19.

Organizations: Universităţii Locations: Wuhan, China

☆ Franţa îndeamnă Uniunea Europeană să nu recunoască vaccinurile fabricate de China şi Rusia
▼ + stars: | 2021-07-08 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +1 min

Franţa îndeamnă Uniunea Europeană să nu recunoască vaccinurile fabricate de China şi Rusia. "Sunt unele țări, precum Spania, care au fost tentate, la un moment dat, să recunoască vaccinurile rus și chinez. Le-am spus partenerilor europeni să fie atenți la acest subiect și să spună "NU" acestor vaccinuri." La mijlocul lunii mai, ţările din UE au decis să permită accesul turiştilor vaccinaţi cu seruri aprobate de Agenţia Europeană pentru Medicamente şi Organizaţia Mondială a Sănătăţii. Ţările care au administrat vaccinuri neautorizate de Agenţia Europeană a Medicamentului şi OMS au încheiat acorduri bilaterale pentru a permite deplasarea liberă a cetăţenilor.

Persons: Clement Beaune, Johnson, Le, OMS Organizations: Europeană, Afaceri, OMS Locations: China, Rusia, francez, Pfizer, Spania, Moderna, AstraZeneca, Moscova

☆ В Молдове растет число желающих сделать прививку от коронавируса. Что еще показал опрос минздрава
▼ + stars: | 2021-07-08 | by ( ) newsmaker.md time to read: +2 min

Число жителей Молдовы, намеренных привиться от коронавируса, значительно увеличилось за последние три месяца. Опрос также показал, сколько человек сделали прививки в Румынии, и сколько жителей страны все еще не верят в существование ковида. Как показали результаты опроса, проведенного минздравом, 57% респондентов готовы привиться от коронавируса. Каждый четвертый взрослый в Молдове (28%) по-прежнему не верит в существование коронавируса. ***По последним данным минздрава, в Молдове хотя бы одной дозой привилось от коронавируса более 760 тыс.

Organizations: Спутник, Национальное агентство общественного здоровья (НАОЗ) Locations: Молдова, Румыния

☆ Спутник V чаще всего выбирают для вакцинации в Приднестровье
▼ + stars: | 2021-07-08 | by ( ) ehomd.info time to read: +1 min

В Приднестровье самым востребованным препаратом от коронавирусной инфекции оказалась российская вакцина Спутник V. Первый компонент этого препарата получили 40 725 человека. Об этом 8 июля сообщило Министерство здравоохранения Приднестровья. Согласно данным, опубликованным Минздравом, полностью завершили иммунизацию от коронавируса 40 029 приднестровцев – 8,6% населения региона. Первой дозой охвачено 69 408 человек. Это составляет 14,9% от общего количества населения региона.

Persons: Спутник Organizations: Министерство здравоохранения, Минздрав Locations: Приднестровье

☆ „Vaccinul nu ne face rău, ci din contra ne protejează sănătatea”, interviu cu Ludmila Negară, asistentă medicală superioară la Centrul Municipal de Vaccinare
▼ + stars: | 2021-07-08 | by ( Onixmedia Srl | ) diez.md time to read: +5 min

„Vaccinul nu ne face rău, ci din contra ne protejează sănătatea”, interviu cu Ludmila Negară, asistentă medicală superioară la Centrul Municipal de VaccinareLudmila Negară este asistentă medicală superioară la Centrul Municipal de Vaccinare din orașul Chișinău. La Centru, doamna Ludmila activează din luna aprilie, atunci când acesta a fost inaugurat. Procesul de imunizare la Centrul Municipal de VaccinareCentrul Municipal de Vaccinare a fost chiar de la început foarte bine organizat. Centrul Municipal de Vaccinare este amplasat pe două etaje și în total sunt șase puncte de vaccinare. Noi am vaccinat în cadrul Centrului și persoane cu boli cronice și boli cancerigene, ceea ce înseamnă că vaccinul este sigur și ne protejează.

Persons: Ludmila Negară, Ludmila, Imunizarea Organizations: World, Ministerul Federal Locations: Chișinău, Republica Moldova, Maraton, Mannheim, Cernăuți

☆ Аргентина отчиталась о побочных эффектах «Спутника». Что стало известно после 7 млн введенных доз?
▼ + stars: | 2021-07-07 | by ( ) nokta.md time to read: +3 min

Минздрав Аргентины опубликовал отчет о побочных эффектах трех вакцин, применяемых в стране, в том числе «Спутника V». Из публикации следует, что на почти семь миллионов доз «Спутника» приходится менее 0,1% серьезных побочных эффектов. На «Спутник» — как самую распространенную в стране вакцину — приходится большинство отчетов о побочных эффектах. Всего для «Спутника V» было зарегистрировано 38 098 побочных эффектов (из 45,7 тысячи побочек от всех вакцин). Из 45,7 тысяч записей о побочных эффектах всех вакцин 307 случаев были признаны тяжелыми — то есть потребовавшими госпитализации.

Persons: Carla Vizzotti Organizations: AstraZeneca Sinopharm, Sputnik, Минздрав, Спутник Locations: Argentina, Аргентина, Россия, Индия

☆ Полный курс вакцинации завершили 8,5% жителей Приднестровья – Цензура МД
▼ + stars: | 2021-07-07 | by ( ) cenzura.md time to read: +1 min

Регионы Полный курс вакцинации завершили 8,5% жителей ПриднестровьяВ Приднестровье продолжается кампания по вакцинации против коронавирусной инфекции. К 7 июля полный курс вакцинации прошли 8,5% приднестровцев. Как сообщает Министерство здравоохранения Приднестровья, полный курс завершили 39 469 приднестровцев – 8,5% населения. Первую прививку сделали 68 661 человек. За все время пандемии подтверждено — 50 027 случаев.

Persons: человекаМинздрав Organizations: Министерство здравоохранения Locations: ПриднестровьяВ Приднестровье, Приднестровье

☆ "După votare, la vaccinare". Punctele de imunizare vor lucra în duminica alegerilor parlamentare
▼ + stars: | 2021-07-06 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: 1 min

Ministerul Sănătăţii anunţă că în duminica alegerilor parlamentare toate punctele de vaccinare din ţară vor activa. "Cu sloganul "După votare, la vaccinare" contăm să asigurăm accesul la cât mai mulţi cetăţeni să ajungă la vaccinare, dacă nu au putut până acum. ", a comunicat secretarul de stat la Ministerul Sănătăţii, Denis Cernelea. Moldovenii care vor decide să se imunizeze după votare, vor avea de ales între vaccinurile AstraZeneca, Sinovac şi Sinopharm. În prezent, în ţară sunt deschise peste 520 de puncte de imunizare care dispun de aproape 300 de mii de doze vaccin.

Persons: Denis Cernelea

☆ Persoanele care s-au vaccinat cu prima doză Sputnik V la sfârșitul lunii iunie, în cadrul maratonului de la Palatul Republicii, își vor putea face rapelul pe 17 iulie
▼ + stars: | 2021-07-06 | by ( Milena Onisim | ) www.zdg.md time to read: +1 min

Primarul general al capitalei, Ion Ceban, anunță că persoanele care s-au vaccinat cu prima doză Sputnik V la sfârșitul lunii iunie, în cadrul maratonului de la Palatul Republicii, își vor putea face rapelul sâmbătă, 17 iulie. „Pe 26 iunie, la Palatul Republicii au venit 4 362 de oameni pentru a se imuniza anti-COVID-19. Cei mai mulți au optat pentru serul Sputnik, iar stocul de 4 000 de doze a fost epuizat până la amiază. Un nou maraton de vaccinare împotriva COVID-19 s-a desfășurat, pe 26 iunie, la Palatul Republicii. În cadrul maratonului a fost posibilă vaccinarea cu serurile Sputnik V, AstraZeneca, Sinovac și Sinopharm.

Persons: Ion Organizations: Facebook, Sputnik Locations: Republicii, Chișinău, AstraZeneca, Moldova, Pfizer, Sinopharm

☆ В Молдове разработали новый план ограничений из-за коронавируса. Что рассказали в минздраве и при чем тут «индийский» штамм
▼ + stars: | 2021-07-06 | by ( ) newsmaker.md time to read: +2 min

В министерстве здравоохранения Молдовы уже разработали возможный план введения новых ограничений для того, чтобы не допустить распространение в стране «индийского» штамма коронавируса. На минувшей неделе Молдова направила в лабораторию в Германии пробы, чтобы определить, есть ли в стране штамм коронавируса дельта (так называемый «индийский» штамм). «Мы рассмотрели и не исключаемэту возможность, [что в Молдове выявят штамм дельта]. Поэтому совместно со специалистами Национального агентства общественного здоровья разработали рекомендации и отправили их на рассмотрение Национальной чрезвычайной комиссии общественного здоровья. Прививаться надо в любом случае, независимо от того выявлен в Молдове дельта, гамма или бета-штамм», — подытожила Ревенко.

Persons: Sinopharm, Денис Чернеля, Нинель Ревенко, Ревенко, Нинель Organizations: AstraZeneca, Национальное агентство общественного здоровья, Национальная чрезвычайная комиссия общественного здоровья, Спутник, Национальное агентство общественного здоровья (НАОЗ) Locations: Молдова, Германия

Search resuls for: "Sinopharm"

25 mentions found